| Results summary | View all lists in GO:BiolProc | View all genes in B01AA.profile.d50 |
|
A form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases, whose actions dismantle the cell and result in cell death. Apoptosis begins internally with condensation and subsequent fragmentation of the cell nucleus (blebbing) while the plasma membrane remains intact. Other characteristics of apoptosis include DNA fragmentation and the exposure of phosphatidyl serine on the cell surface. enrichment: 2.25-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 202925_S_AT | PLAGL2 | G | R | pleiomorphic adenoma gene-like 2 | |||||||||
| 208424_S_AT | CIAPIN1 | G | cytokine induced apoptosis inhibitor 1 | ||||||||||
| 208050_S_AT | CASP2 | G | P | S | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) | ||||||||
| 209311_AT | BCL2L2 | G | D | BCL2-like 2 | |||||||||
| 218833_AT | ZAK | G | X | P | S | sterile alpha motif and leucine zipper containing kinase AZK | |||||||
| 215404_X_AT | FGFR1 | G | D | P | C | S | fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome) | ||||||